The Role of Cognitive-Behavioral Therapy and Fluoxetine in Prevention of Recurrence of Major Depressive Disorder
The DOI matches its Crossref record; 35 of the 36 references it cites were found in a registry or an index.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
An inventory for measuring depression
BECK, A. T. (1961) · Archives of General Psychiatry · doi:10.1001/archpsyc.1961.01710120031004 · Cited by 38,032 · cited 4×
“…the 92-item Symptom Questionnaire (SQ; Kellner 1987), the Beck Hopelessness Scale (BHS; Beck et al. 1974), the Beck Depression Inventory (BDI; Beck et al. 1961), the Patient Global Impression of Improvement (PGI-I; Guy 1976), and the Beck Anxiety Inventory (BAI; Beck et al. 1988) at the…”
MethodInfluentialHamilton, M. (1960) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.23.1.56 · Cited by 32,817 · cited 7×
“The remaining remitters (n = 132; 54.5% female; mean age 39.9 ± 10.3) to this acute phase treatment [remission = 17-item Hamilton Rating Scale for Depression (HAMD-17; Hamilton 1960 )] £7 for three consecutive weeks) were randomized to two, 28-week continuation phase treatment groups: (1) increase in fluoxetine to fix…”
MethodInfluentialAn inventory for measuring clinical anxiety: Psychometric properties.
Beck, A. T., Epstein, N., Brown, G., & Steer, R. A. (1988) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.56.6.893 · Cited by 14,407 · cited 4×
“Anxiety Inventory (BAI; Beck et al. 1988) at the conclusion of each study visit.”
BackgroundMethodInfluentialJournal of Clinical Psychiatry
(2018) · Journal of Clinical Psychiatry · doi:10.5505/kpd · Cited by 13,651
Cognitive Therapy for Depression: (675542012-001)
(2012) · PsycEXTRA Dataset · doi:10.1037/e675542012-001 · Cited by 9,663
(1976) · Medical Entomology and Zoology · Cited by 8,899
Cohen, J. (1992) · Psychological Bulletin · doi:10.1037//0033-2909.112.1.155 · Cited by 8,771
The measurement of pessimism: the hopelessness scale
Beck, A. T., Weissman, A., Lester, D., & Trexler, L. (1974) · Journal of Consulting and Clinical Psychology · doi:10.1037/h0037562 · Cited by 5,494 · cited 4×
“BAI = Beck Anxiety Inventory; BDI = Beck Depression Inventory; HAMD-17 = 17-item Hamilton Rating Scale for Depression; CGI-I = Clinical Global Impressions, Improvement; PGI-I = Patient Global Impressions, Improvement; CGI-S = Clinical Global Impressions, Severity; SQ = Symptom Questionnaire; BHS = Beck Hopelessness Sc…”
MethodInfluentialCognitive Therapy of Depression
HOLLON, S. D., & BECK, A. T. (1979) · Cognitive-Behavioral Interventions · doi:10.1016/b978-0-12-404480-7.50012-5 · Cited by 4,685
Prevention of relapse/recurrence in major depression by mindfulness-based cognitive therapy.
Teasdale, J. D., Segal, Z. V., Williams, J. M. G., Ridgeway, V. A., Soulsby, J. M., & Lau, M. A. (2000) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.68.4.615 · Cited by 3,236 · cited 11×
“Past research suggests that medication maintenance prevents recurrence (Fava and Kaji 1994; Keller et al. 1998), and the addition of CBT methods to medication maintenance confers a long-term treatment advantage (Paykel et al. 1999; Teasdale et al. 2000).”
BackgroundResultInfluential
Research works printed but not linked: 2
- Fawcett, J., Epstein, P., Fiester, S. J., Elkin, I., & Autry, J. H. (1987). Clinical management: Imipramine/placebo administration manual. Psychopharmacology Bulletin, 23, 309–323.
- Spitzer, R. L., Williams, J. B. W., Gibbon, M., & First, M. B. (1989). Structured clinical interview for DSM-III-R—Patient Edition (SCID-P, 9/1/89 Version). New York: Biometrics Research.
Cited by
Pryce, C. R., Azzinnari, D., Spinelli, S., Seifritz, E., Tegethoff, M., & Meinlschmidt, G. (2011) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2011.06.006 · Cited by 241
Relapse and recurrence prevention in depression: Current research and future prospects
Beshai, S., Dobson, K. S., Bockting, C. L. H., & Quigley, L. (2011) · Clinical Psychology Review · doi:10.1016/j.cpr.2011.09.003 · Cited by 165
“%) in comparison to control (62%), 1.32a (1.01–1.73) CT, AMD Petersen et al. (2010) N=52; Combined continuation CT+ADM (Fluoxetine) vs. ADM alone vs. CT+placebo vs. Placebo alone.”
BackgroundInfluentialVan Leeuwen, E., van Driel, M. L., Horowitz, M. A., Kendrick, T., Donald, M., De Sutter, A. I., Robertson, L., & Christiaens, T. (2021) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd013495.pub2 · Cited by 90
Managing antidepressant discontinuation: a systematic review
Maund, E., Stuart, B., Moore, M., Dowrick, C., Geraghty, A. W. A., Dawson, S., & Kendrick, T. (2019) · The Annals of Family Medicine · doi:10.1370/afm.2336 · Cited by 82
Rodgers, M., Asaria, M., Walker, S., McMillan, D., Lucock, M. P., Harden, M., Palmer, S., & Eastwood, A. J. (2012) · Health Technology Assessment · doi:10.3310/hta16280 · Cited by 85
Metadata
- Authors
- Petersen, T. J., Pava, J. A., Buchin, J., Matthews, J. D., Papakostas, G. I., Nierenberg, A. A., Holmes, A. J., Bogdan, R., Graves, L. M., Harley, R. M., & Fava, M.
- Affiliations
- Massachusetts General Hospital (US)
- Harvard University (US)
- Corresponding author
- Petersen, Timothy J.
- Venue
- Cognitive Therapy and Research
- Published
- 2007-10-01
- Volume
- 34
- Issue
- 1
- Pages
- 13-23
- ISSN
- 0147-5916 (ISSN-L)
- 1573-2819
- OpenAlex
- W2139752051
- Cited by
- 14
- References
- 36
- Citations by year
- 2025: 1 · 2024: 1 · 2022: 1 · 2021: 1 · 2020: 1 · 2019: 1 · 2017: 1 · 2016: 1 · 2015: 1 · 2013: 2 · 2012: 1
- FWCI
- 0.00
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Cognitive Therapy and Research (publishedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Social Sciences › Psychology › Clinical Psychology › Psychotherapy Techniques and Applications
- Keywords
- cognitive behavioral therapy, fluoxetine, major depressive disorder, recurrence prevention, maintenance therapy, remitted depression, continuation treatment, antidepressant treatment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The Role of Cognitive-Behavioral Therapy and Fluoxetine in Prevention of Recurrence of Major Depressive Disorder. https://app.cochat.ai/papers/10.1007/s10608-007-9166-6
- The paper
- Petersen, T. J., Pava, J. A., Buchin, J., Matthews, J. D., Papakostas, G. I., Nierenberg, A. A., Holmes, A. J., Bogdan, R., Graves, L. M., Harley, R. M., & Fava, M. (2010). The Role of Cognitive-Behavioral Therapy and Fluoxetine in Prevention of Recurrence of Major Depressive Disorder. Cognitive Therapy and Research. https://doi.org/10.1007/s10608-007-9166-6
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.